Literature DB >> 17302894

Factors involved in the generation of memory CD8+ T cells in patients with X-linked lymphoproliferative disease (XLP).

L Belmonte1, C Parodi, P Baré, A Malbrán, B Ruibal-Ares, María M de E de Bracco.   

Abstract

UNLABELLED: We have analysed the phenotype of T lymphocytes in two X-linked lymphoproliferative disease (XLP) patients with the same SH2D1A mutation differing in initial exposure to Epstein-Barr virus (EBV) and treatment. While memory T lymphocytes (with low CCR7 and CD62L expression) prevailed in both XLP patients, in patient 9, who developed acute infectious mononucleosis (AIM) and received B cell ablative treatment, the predominant phenotype was that of late effector CD8 T cells (CD27-, CD28-, CCR7-, CD62L-, CD45 RA+, perforin+), while in patient 4 (who did not suffer AIM) the prevalent phenotype of CD8 T lymphocytes was similar to that of normal controls (N) or to that of adult individuals who recovered from AIM: CD27+ , CD28+, CCR7-, CD62L-, CD45 RO+ and perforin-. CD57 expression (related to senescence) was also higher in CD8 T cells from patient 9 than in patient 4, AIM or N. Persistently high EBV viral load was observed in patient 9. The results obtained from this limited number of XLP patients suggest that events related to the initial EBV encounter (antigen load, treatment, cytokine environment) may have more weight than lack of SH2D1A in determining the long-term differentiation pattern of CD8 memory T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302894      PMCID: PMC1810493          DOI: 10.1111/j.1365-2249.2006.03300.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential.

Authors:  Padraic J Dunne; Jeffery M Faint; Nancy H Gudgeon; Jean M Fletcher; Fiona J Plunkett; Maria Vieira D Soares; Andrew D Hislop; Nicola E Annels; Alan B Rickinson; Mike Salmon; Arne N Akbar
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

2.  Lineage relationship and protective immunity of memory CD8 T cell subsets.

Authors:  E John Wherry; Volker Teichgräber; Todd C Becker; David Masopust; Susan M Kaech; Rustom Antia; Ulrich H von Andrian; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

3.  The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.

Authors:  Michael R Betts; David A Price; Jason M Brenchley; Karin Loré; F Javier Guenaga; Anna Smed-Sorensen; David R Ambrozak; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

4.  The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.

Authors:  Laila E Gamadia; Ester M M van Leeuwen; Ester B M Remmerswaal; Si-La Yong; Sugianto Surachno; Pauline M E Wertheim-van Dillen; Ineke J M Ten Berge; René A W Van Lier
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 5.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

Review 6.  The role of programming in memory T-cell development.

Authors:  David Masopust; Susan M Kaech; E John Wherry; Rafi Ahmed
Journal:  Curr Opin Immunol       Date:  2004-04       Impact factor: 7.486

7.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

8.  Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics.

Authors:  J M Faint; N E Annels; S J Curnow; P Shields; D Pilling; A D Hislop; L Wu; A N Akbar; C D Buckley; P A Moss; D H Adams; A B Rickinson; M Salmon
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

9.  Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Authors:  Jason M Brenchley; Nitin J Karandikar; Michael R Betts; David R Ambrozak; Brenna J Hill; Laura E Crotty; Joseph P Casazza; Janaki Kuruppu; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

10.  Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection.

Authors:  Alejandro Malbran; Liliana Belmonte; Beatriz Ruibal-Ares; Patricia Baré; Ivana Massud; Cecilia Parodi; Marta Felippo; Richard Hodinka; Kathleen Haines; Kim E Nichols; María M de Bracco
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.